SE8702843L - Ny anvendning av bromokriptin - Google Patents

Ny anvendning av bromokriptin

Info

Publication number
SE8702843L
SE8702843L SE8702843A SE8702843A SE8702843L SE 8702843 L SE8702843 L SE 8702843L SE 8702843 A SE8702843 A SE 8702843A SE 8702843 A SE8702843 A SE 8702843A SE 8702843 L SE8702843 L SE 8702843L
Authority
SE
Sweden
Prior art keywords
bromoccriptin
new use
disease
autoimmune
bromocriptine
Prior art date
Application number
SE8702843A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Other versions
SE8702843D0 (sv
Inventor
D Larson
P Hiestand
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8702843D0 publication Critical patent/SE8702843D0/xx
Publication of SE8702843L publication Critical patent/SE8702843L/

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE8702843A 1986-07-14 1987-07-13 Ny anvendning av bromokriptin SE8702843L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88511086A 1986-07-14 1986-07-14

Publications (2)

Publication Number Publication Date
SE8702843D0 SE8702843D0 (sv) 1987-07-13
SE8702843L true SE8702843L (sv) 1988-01-15

Family

ID=25386156

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8702843A SE8702843L (sv) 1986-07-14 1987-07-13 Ny anvendning av bromokriptin

Country Status (13)

Country Link
JP (1) JPS6323817A (enrdf_load_stackoverflow)
KR (1) KR880001292A (enrdf_load_stackoverflow)
AU (1) AU602154B2 (enrdf_load_stackoverflow)
CH (1) CH672987A5 (enrdf_load_stackoverflow)
DE (1) DE3722383A1 (enrdf_load_stackoverflow)
DK (1) DK363887A (enrdf_load_stackoverflow)
FR (1) FR2601245A1 (enrdf_load_stackoverflow)
GB (1) GB2192541B (enrdf_load_stackoverflow)
IT (1) IT1224222B (enrdf_load_stackoverflow)
NL (1) NL8701631A (enrdf_load_stackoverflow)
PH (1) PH24525A (enrdf_load_stackoverflow)
SE (1) SE8702843L (enrdf_load_stackoverflow)
ZA (1) ZA875145B (enrdf_load_stackoverflow)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3814521A1 (de) * 1987-05-07 1988-11-17 Sandoz Ag Neue anwendung von dopaminrezeptor-agonisten
EP0327040A3 (de) * 1988-02-05 1990-11-28 Predrag Dr.Sc. Sikiric Verwendung von Dopamin und/oder von Dopamin-Agonisten zur Herstellung eines Arzneimittels für die Behandlung des Verdauungstrakts
US5716932A (en) * 1988-05-10 1998-02-10 Louisiana State University And Agricultural And Mechanical College Process for the long term reduction of body fat stores, insulin resistance, and hyperinsulinemia in vertebrates
US6004972A (en) * 1988-05-10 1999-12-21 The Board Of Supervisiors Of Louisiana State University And Agricultural And Mechanical College Therapeutic process for the treatment of the pathologies of type II diabetes
US5700800A (en) * 1988-05-10 1997-12-23 Ergo Science Incorporated Methods for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates with a prolactin stimulatory compound
US5585347A (en) * 1988-05-10 1996-12-17 Ergo Science Incorporated Methods for the determination and adjustment of prolactin daily rhythms
US5744477A (en) * 1988-05-10 1998-04-28 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Method for treatment of obesity using prolactin modulators and diet
US5830895A (en) * 1988-05-10 1998-11-03 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Methods for the determination and adjustment of prolactin daily rhythms
US5468755A (en) * 1988-05-10 1995-11-21 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Therapeutic process for the treatment of the pathologies of Type II diabetes
US5668155A (en) * 1988-05-10 1997-09-16 The General Hospital Corporation Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders
US5344832A (en) * 1990-01-10 1994-09-06 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates
CA2030174C (en) * 1990-01-10 1996-12-24 Anthony H. Cincotta Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hypoglycemia in vertebrates
WO1993012793A1 (en) * 1991-12-23 1993-07-08 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College A therapeutic process for the treatment of the pathologies of type ii diabetes
US5696128A (en) * 1994-07-07 1997-12-09 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method of regulating immune function
IL112106A0 (en) * 1993-12-22 1995-03-15 Ergo Science Inc Accelerated release composition containing bromocriptine
US5714519A (en) * 1995-06-07 1998-02-03 Ergo Science Incorporated Method for regulating glucose metabolism
US5626860A (en) * 1995-06-07 1997-05-06 The Board Of Supervisors Of Louisana State And Agricultural And Mechanical College Method for regulating metabolism with dopamine beta hydroxylase inhibitors
US20010016582A1 (en) 1997-04-28 2001-08-23 Anthony H. Cincotta Method and composition for the treatment of lipid and glucose metabolism disorders
JP5407865B2 (ja) * 2006-11-23 2014-02-05 ジノクサ ファルマ ゲーエムベーハー 毛細管動脈疾患治療用医薬組成物
DK3445362T3 (da) * 2016-04-20 2021-10-11 Veroscience Llc Sammensætning og fremgangsmåde til behandling af stofskiftesygdomme
PL3697418T3 (pl) 2017-10-18 2025-02-03 Veroscience Llc Polepszone preparaty bromokryptyny
CA3149877A1 (en) 2019-09-23 2021-04-01 Anthony H. Cincotta Method for inducing tumor regression

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH507249A (de) * 1968-05-31 1971-05-15 Sandoz Ag Verfahren zur Herstellung von 2-Brom-a-ergokryptin
CH666406A5 (de) * 1984-02-29 1988-07-29 Sandoz Ag Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten.
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions

Also Published As

Publication number Publication date
GB2192541B (en) 1990-05-02
KR880001292A (ko) 1988-04-22
NL8701631A (nl) 1988-02-01
JPS6323817A (ja) 1988-02-01
DK363887D0 (da) 1987-07-13
GB2192541A (en) 1988-01-20
GB8716323D0 (en) 1987-08-19
FR2601245A1 (fr) 1988-01-15
CH672987A5 (enrdf_load_stackoverflow) 1990-01-31
DE3722383A1 (de) 1988-01-28
DK363887A (da) 1988-01-15
IT1224222B (it) 1990-09-26
AU602154B2 (en) 1990-10-04
SE8702843D0 (sv) 1987-07-13
ZA875145B (en) 1989-02-22
PH24525A (en) 1990-07-18
IT8748160A0 (it) 1987-07-10
AU7558787A (en) 1988-01-21

Similar Documents

Publication Publication Date Title
SE8702843L (sv) Ny anvendning av bromokriptin
FI873280A7 (fi) Serotoniiniantagonistien terapeuttinen käyttö.
FR2543959B1 (fr) Copolymere convenant specialement a la preparation de lentilles de contact molles et contenant de l'eau
NO873351D0 (no) Haarrensemiddelblanding og anvendelse av denne.
DK440786D0 (da) Insekticidt praeparat, deri indgaaende syntetiske pyrethroider og dissesfremstilling samt praepatets anvendelse
OA09362A (en) "Production and use of porphyrins".
IT1227064B (it) Poliuretani fluorurati, contenenti blocchi poliossiperfluoroalchileni ci aventi migliorate propieta' meccaniche
GB8621932D0 (en) Speech coding
BR8704628A (pt) Utilizacao de poliois ou misturas de poliois
DE3270334D1 (en) Organic peroxides and use of same
AR245190A1 (es) Procedimiento para preparar oxidato de petroleo sobrebasificado.
AU8192987A (en) Human ldh-c4 cdna sequences encoding antigenic regions
ZA872754B (en) Electrochemical reduction of iodopolyfluoroalkanes and fluorinated compounds thereby obtained
SE8705060L (sv) Antiforkylningssats, antiforkylningspreparat och anvendning derav
GB8616228D0 (en) Forming ring body of bearing
GB8706726D0 (en) Determination of water
GB8700776D0 (en) Disabled person's aid
DK468488D0 (da) Konserveret haar- og legemsrensemiddel samt anvendelse af en konserveringsstof-kombination
KR870015953U (ko) 나침반이 부설된 열쇠고리
ZA873391B (en) Chlorination of water
Willis Dreams of Darkness: Fantasy and the Films of Val Lewton
ES1004662Y (es) Dispositivo de flotacion con medios de retencion del cuerpo del usuario.
IT8982515A0 (it) Strutturazione funzionale per l'immissione dell'utente nell'ordine alfabetico del dizionario.
GB8602186D0 (en) Remote user interface
ES270669U (es) Banera.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8702843-7

Effective date: 19920201

Format of ref document f/p: F